Gyre Therapeutics Inc (STU:L9S)
€ 13.6 -0.1 (-0.73%) Market Cap: 1.33 Bil Enterprise Value: 1.30 Bil PE Ratio: 0 PB Ratio: 21.33 GF Score: 30/100

Q3 2021 Catalyst Biosciences Inc Earnings Call Transcript

Nov 12, 2021 / 01:30PM GMT
Operator

Welcome to the Catalyst Biosciences Corporate Update Conference Call. This call is being recorded. (Operator Instructions) I would now like to turn the call over to Catalyst Biosciences. Please go ahead.

Ana Kapor
Catalyst Biosciences, Inc. - Senior Director of IR & Corporate Communications

Thank you, operator, and good morning, everyone. Earlier today, we issued a press release announcing our corporate strategy update. You may access that release and the company's website under the Investors tab. With us today are Dr. Nassim Usman, President and Chief Executive Officer; and Dr. Grant Blouse, Chief Scientific Officer.

Following our prepared remarks, we will open the call for a question-and-answer session. Before we begin, I would like to remind you that various remarks that we make on this call contain forward-looking statements, including statements regarding expected regulatory and clinical actions and development and projected operating expenses. These statements are subject to risks, uncertainties and other factors that could cause actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot